Inventor
BABICH JOHN W
US59 patents
⚠️ This page may combine multiple inventors who share the name “BABICH JOHN W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MOLECULAR INSIGHT PHARM INC
22 patentsUS8962799B2Feb 24, 2015
Technetium—and rhenium-bis(heteroaryl) complexes and methods of use thereof
MOLECULAR INSIGHT PHARM INC75 citations97
US8840865B2Sep 23, 2014
Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof
MOLECULAR INSIGHT PHARM INC32 citations97
US7052913B2May 30, 2006
Matrices for drug delivery and methods for making and using the same
MOLECULAR INSIGHT PHARM INC18 citations89
US10131627B2Nov 20, 2018
Heterodimers of glutamic acid
MOLECULAR INSIGHT PHARM INC4 citations84
US9878980B2Jan 30, 2018
Heterodimers of glutamic acid
MOLECULAR INSIGHT PHARM INC5 citations84
US7381399B2Jun 3, 2008
Technetium-dipyridine complexes, and methods of use thereof
MOLECULAR INSIGHT PHARM INC12 citations84
US10086096B2Oct 2, 2018
Triazine based radiopharmaceuticals and radioimaging agents
MOLECULAR INSIGHT PHARM INC4 citations83
US9956305B2May 1, 2018
Organ protection in PSMA-targeted radionuclide therapy of prostate cancer
MOLECULAR INSIGHT PHARM INC8 citations83
US9447121B2Sep 20, 2016
Triazine based radiopharmaceuticals and radioimaging agents
MOLECULAR INSIGHT PHARM INC10 citations83
US9433594B2Sep 6, 2016
Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof
MOLECULAR INSIGHT PHARM INC5 citations83
US9388144B2Jul 12, 2016
Radiolabeled prostate specific membrane antigen inhibitors
MOLECULAR INSIGHT PHARM INC9 citations83
US10647666B2May 12, 2020
Heterodimers of glutamic acid
MOLECULAR INSIGHT PHARM INC2 citations73
US10640461B2May 5, 2020
Heterodimers of glutamic acid
MOLECULAR INSIGHT PHARM INC2 citations73
US10898598B2Jan 26, 2021
Triazine based radiopharmaceuticals and radioimaging agents
MOLECULAR INSIGHT PHARM INC1 citations72
US10201624B2Feb 12, 2019
Triazine based radiopharmaceuticals and radioimaging agents
MOLECULAR INSIGHT PHARM INC3 citations72
US9120837B2Sep 1, 2015
Metal complexes of poly(carboxyl)amine-containing ligands having an affinity for carbonic anhydrase IX
MOLECULAR INSIGHT PHARM INC5 citations72
US7556794B2Jul 7, 2009
Pendant fatty acid imaging agents
MOLECULAR INSIGHT PHARM INC3 citations63
US7179444B2Feb 20, 2007
Pendant fatty acid imaging agents
MOLECULAR INSIGHT PHARM INC3 citations63
US12534429B2Jan 27, 2026
Heterodimers of glutamic acid
MOLECULAR INSIGHT PHARM INC0 citations62
US11712485B2Aug 1, 2023
Triazine based radiopharmaceuticals and radioimaging agents
MOLECULAR INSIGHT PHARM INC0 citations62
US11167049B2Nov 9, 2021
Organ protection in PSMA-targeted radionuclide therapy of prostate cancer
MOLECULAR INSIGHT PHARM INC0 citations62
US7141573B2Nov 28, 2006
Polypharmacophoric agents
MOLECULAR INSIGHT PHARM INC3 citations62
UNIV CORNELL
9 patentsUS11279698B2Mar 22, 2022
Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer
UNIV CORNELL7 citations84
US10806806B2Oct 20, 2020
Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies
UNIV CORNELL8 citations82
US10179117B2Jan 15, 2019
Double targeted constructs to affect tumor kill
UNIV CORNELL6 citations82
US11285227B2Mar 29, 2022
Trifunctional constructs with tunablepharmacokinetics useful in imaging and anti-tumor therapies
UNIV CORNELL6 citations73
US12377175B2Aug 5, 2025
Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies
UNIV CORNELL0 citations61
US12268759B2Apr 8, 2025
Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies
UNIV CORNELL0 citations61
US12258339B2Mar 25, 2025
Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer
UNIV CORNELL0 citations61
US12186288B2Jan 7, 2025
Double targeted constructs to affect tumor kill
UNIV CORNELL0 citations61
US12103922B2Oct 1, 2024
Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer
UNIV CORNELL0 citations61
BABICH JOHN W
8 patentsUS9309193B2Apr 12, 2016
Heterodimers of glutamic acid
BABICH JOHN W41 citations97
US8926944B2Jan 6, 2015
Radiolabeled prostate specific membrane antigen inhibitors
BABICH JOHN W60 citations97
US8487129B2Jul 16, 2013
Heterodimers of glutamic acid
BABICH JOHN W54 citations97
US8211401B2Jul 3, 2012
Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof for inhibiting PSMA
BABICH JOHN W93 citations97
US8465725B2Jun 18, 2013
Process for production of heterodimers of glutamic acid
BABICH JOHN W42 citations94
US9687572B2Jun 27, 2017
PSMA-targeted dendrimers
BABICH JOHN W30 citations93
US8211402B2Jul 3, 2012
CA-IX specific radiopharmaceuticals for the treatment and imaging of cancer
BABICH JOHN W46 citations93
US8562945B2Oct 22, 2013
Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof
BABICH JOHN W31 citations91
BIOSTREAM INC
3 patentsUS6491893B1Dec 10, 2002
Compounds for targeting and imaging infection and inflammation
BIOSTREAM INC64 citations96
US6395299B1May 28, 2002
Matrices for drug delivery and methods for making and using the same
BIOSTREAM INC194 citations94
US6437103B1Aug 20, 2002
Fatty acid analogs for diagnosis of coronary artery disease
BIOSTREAM INC22 citations89
GEN HOSPITAL CORP
3 patentsUS6187286B1Feb 13, 2001
Tumor imaging agents, methods and kits
GEN HOSPITAL CORP34 citations93
US7060251B1Jun 13, 2006
Imaging agents for early detection and monitoring of cardiovascular plaque
GEN HOSPITAL CORP14 citations84
US6299857B1Oct 9, 2001
Cardiovascular and thrombus imaging agents, methods and kits
GEN HOSPITAL CORP11 citations73
ASS UNIVERSITIES INC
2 patentsZIMMERMAN CRAIG
1 patentJMDE TRUST
1 patentBIOSTREAM THERAPEUTICS INC
1 patentShowing the top 50 of 59 patents by PatentIndex Score.